Navigation Links
MAP Pharmaceuticals Reports Third Quarter of 2008 Financial Results

ectations based on risks and uncertainties affecting MAP Pharmaceuticals' business, including, without limitation, risks and uncertainties relating to the enrollment and conduct of clinical trials, as well as risks related to the failure to achieve favorable clinical outcomes and that MAP Pharmaceuticals' product candidates will not be approved for commercial use by the U.S. Food and Drug Administration. The reader is cautioned not to unduly rely on the forward-looking statements contained in this press release. MAP Pharmaceuticals expressly disclaims any intent or obligation to update these forward-looking statements, except as required by law. Additional information on potential factors that could affect MAP Pharmaceuticals' results and other risks and uncertainties are detailed in its Quarterly Report on Form 10-Q, filed with the SEC on August 13, 2008, and available at .


(a development stage enterprise)


(In thousands)


September 30, December 31,

2008 2007


Current assets:

Cash, cash equivalents and short-term

investments $63,021 $94,990

Other current assets 525 1,079

Total current assets 63,546 96,069

Property and equipment, net 4,927 4,183

Restricted cash 310 321

Other assets 27 122

Total assets

SOURCE MAP Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Ferring Pharmaceuticals Promotes William Garbarini to Vice President of New Orthopaedics and Urology Business Unit
2. Alexza Pharmaceuticals Announces Upcoming Conference Participation and Webcasts
3. Jazz Pharmaceuticals, Inc. to Announce Third Quarter Financial Results on November 13, 2008
4. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2008 Financial Results
5. MAP Pharmaceuticals to Present at the Lazard Capital Markets 5th Annual Healthcare Conference
6. Keryx Biopharmaceuticals KRX-0401 (Perifosine) Data Selected for Oral Presentation at the 50th Annual Meeting of the American Society of Hematology
7. Duska Therapeutics and DSM Pharmaceuticals in Manufacturing Collaboration for PSVT Drug Product
8. Memory Pharmaceuticals Announces Six Abstracts Accepted for Presentation at Society for Neuroscience Meeting
9. Alseres Pharmaceuticals, Inc. To Host Third Quarter 2008 Conference Call
10. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2008 Financial Results on Tuesday, November 11, at 8:30 A.M. EST
11. Sagent Pharmaceuticals Announces Presentations at Upcoming Lazard Capital Markets and Piper Jaffray Healthcare Conferences
Post Your Comments:
(Date:10/9/2015)... Nedlands, WA, Australia (PRWEB) , ... October 09, ... ... be featured in an upcoming episode of Innovations with Ed Begley Jr., airing ... In this segment, Innovations will educate audiences on MMJ Phytotech Limited (MMJ) – ...
(Date:10/9/2015)... Bethesda, Maryland (PRWEB) , ... October 09, 2015 ... ... care and assisted living placement counseling, recently opened its newest office in Maryland ... the senior care industry with a background as a project management technology consultant ...
(Date:10/9/2015)... ... ... The Kitchenistas of National City, a documentary film on the struggles of ... food, has been selected for viewing at the I Imagine Film Festival on October ... 30-31 in London, England. , The documentary, by San Diego filmmaker Mary Ann Beyster, ...
(Date:10/9/2015)... ... October 09, 2015 , ... Yisrayl Hawkins, Pastor at The House of ... subject of health care back to the beginning, literally, starting in the book of ... be prevented if only biblical laws were being taught. The letter addresses the ...
(Date:10/8/2015)... ... 2015 , ... The Guthrie Sports Medicine/Twin Tiers Sports Post-Concussion ... group was started by Steven Hicks, a Licensed Athletic Trainer, with Guthrie Sports ... in November 2010 to help support student athletes, their families, and ...
Breaking Medicine News(10 mins):
... from Alcon and Initial Payments from New Galderma ... Calif., May 18 NovaBay Pharmaceuticals, Inc. (NYSE ... company developing first-in-class anti-infective products for the treatment ... without causing resistance, reported today its financial results ...
... Health, Travisa Alliance to Improve Total Care for ... commitment to provide clients with a streamlined continuum ... ), the nation,s largest provider of travel medical ... the nation,s leading expeditor of Passports and Visas: ...
... Medical Bill and Payment Support Insurance Industry Corporate ... Mitchell International, Inc., a leading provider of medical ... support tools to over 70% of U.S. automotive ... of eBill Processing and Gateway Services to Workers, ...
... May 18 /PRNewswire-FirstCall/ -- Takeda ... (Nasdaq: IDMI ) today announced that Takeda ... America), and IDM Pharma have entered into an agreement ... has established Jade Subsidiary Corporation as a wholly-owned subsidiary ...
... learn more about public health opportunities before they enroll in school. ... ... the publication of a new public health resource center that gives students ... right decisions for their education and careers. The new resource center is ...
... $1 Million Raised at Annual Nordstrom Beat the Bridge ... May 17, over 9,000 runners, walkers and all manner ... gathered at University of Washington,s Husky Stadium to participate ... Beat Diabetes event to benefit the Northwest Chapter of ...
Cached Medicine News:
(Date:10/9/2015)... MELVILLE, N.Y. , Oct. 9, 2015 ... the world,s largest provider of health care products and ... today reminded its customers that the Henry Schein Disaster ... who experience operational, logistical or financial issues as a ... Carolina . The toll-free number for all ...
(Date:10/9/2015)...  Impax Laboratories, Inc. (NASDAQ: IPXL ) announced ... 2015 financial results on Monday, November 9, 2015, prior ... Company will host a conference call and live webcast ... on November 9, 2015. . ... financial results and live webcast will be accessible through ...
(Date:10/9/2015)... 9, 2015 Eli Lilly and Company (NYSE: ... and approximately 50 new jobs to its research and development ... New York, New York . ... space will include a translational immuno-oncology hub and a Lilly ... collaborative access to cutting-edge drug discovery capabilities, including chemistry and ...
Breaking Medicine Technology:
... JERUSALEM, Oct. 13, 2011 IDenta Corp. (OTC: IDTA) CEO ... Shoham stated, "We are succeeding in making sales in many ... products. We have received an order for 2000 ... In the past several ...
... Association for Homecare urges the Joint Select Committee on ... cuts that will restrict access to home medical ... Over the years, homecare has broadened health care access ... the health care system by keeping seniors and people ...
Cached Medicine Technology:
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: